2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$347.74+$3.02 (+0.88%)
Price as of Jun 23, 2026 2:00 PM EDT- $186.0BMarket Cap
- 30.33%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$347.74+$3.02 (+0.88%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $344.72 | ||
Change | +$7.12 (+2.11%) | ||
Open | $337.65 | ||
High | $345.11 | ||
Low | $337.60 | ||
Previous Close | $337.60 | ||
Volume | 2,520,963 | ||
30-Day Average Volume | 3,141,738 | ||
1-Week Change | -1.66% | ||
1-Month Change | 1.60% | ||
1-Year Change | 30.33% | ||
3-Year Change | 64.59% | ||
5-Year Change | 68.19% | ||
Fundamentals | |||
Shares Outstanding | 539.7M | ||
Total Assets | $92.5B | ||
Market Cap | $186.0B | ||
Enterprise Value | $231.3B | ||
Period: QTR TTM FY | |||
Revenue | $8.2B | ||
Net Income | $1.8B | ||
Free Cash Flow | $1.5B | ||
EBIT | $2.7B | ||
EBITDA | $3.9B | ||
Net Working Capital | $6.5B | ||
EPS | $3.34 | ||
Enterprise Value/EBITDA | 60 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 20 | ||
P/E | 103 | ||
PEG | 3 | ||
Price/Free Cash Flow | 126 | ||
Price/Operating Cash Flow | 85 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.92% | ||
Trailing Annual Dividend Yield | 2.84% | ||
Ex-Dividend Date | 05/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield